Amine and ether compounds which modulate the CB2 receptor
US8957063B2 · kind B2 · utility
6Cited by
11References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2009 |
| Grant date | Feb 17, 2015 |
| Priority date | — |
| Expiry date | Apr 5, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds which modulate the CB2 receptor are disclosed. The compounds are useful for treating CB2 receptor-mediated diseases such as pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.